April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded relea ...

Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s M ...

Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety a ...

Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an ...

Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the firs ...

Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...

Adopting next-generation technologies can help centers stay at the cutting edge of innovative care. However, the burden of ...

Lower extremity intervention via the radial approach became part of our routine outpatient practice in 2016. At that time, ...